Background: It is currently recommended that all patients with liver cirrhosis undergo upper gastrointestinal endoscopy (UGIE) to identify those who have large esophageal varices (LEVx ...

We conducted a retrospective cohort study in an attempt to re-evaluate the clinical significance of variceal bleeding. Methods: A cohort of 304 patients with liver cirrhosis and esophageal varices ...

Esophageal and esophagogastric varices are ... To our knowledge this is a heretofore undescribed source of bleeding in cirrhosis. Case Report A.G. (M.S.H. 317076), a 43-year-old man, was admitted ...

Lamivudine has been reported to improve liver function and histology, reduce hepatic decompensation and hepatocellular carcinoma, suppress HBV replication, and reverse fibrosis in patients with ...

Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 2004; 40: 652–659. 4. Paquet KJ and Feussner H. Endoscopic sclerosis and esophageal balloon ...

Esophageal capsule endoscopy for screening and surveillance of esophageal varices in patients with portal hypertension. Hepatology 47 , 1595–1603 (2008). Article Google Scholar ...

cirrhosis and portal hypertension. In the pre-specified per-protocol population, the 2 mg/kg dose of belapectin significantly reduced the development of esophageal varices compared to placebo (p 0 ...

My hemorrhage was caused by esophageal varices, a serious health condition directly related to liver disease. Shortly after ...

cirrhosis who have clinical signs of portal hypertension and are at risk of developing esophageal varices. Citing data from three patient cohorts who received belapectin 2 mg/kg, belapectin 4 mg ...

All three posters highlighting clinical data will be presented at the "Portal Hypertension and Other Complications of Cirrhosis” session taking place 8:00 am - 5:00 pm on November 18, 2024: Title: ...